Longer Letermovir Prophylaxis Reduced Risk of Cytomegalovirus Infection After HSCT

(MedPage Today) -- Extending the duration of letermovir (Prevymis) prophylaxis following hematopoietic stem cell transplantation (HSCT) was effective in reducing the risk of late clinically significant cytomegalovirus infection, a phase III randomized...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news